Endothelial Dysfunction and Ischemia-Modified Albumin Levels in Males with Diabetic and Nondiabetic Erectile Dysfunction.


Journal

Disease markers
ISSN: 1875-8630
Titre abrégé: Dis Markers
Pays: United States
ID NLM: 8604127

Informations de publication

Date de publication:
2022
Historique:
received: 11 01 2022
revised: 06 04 2022
accepted: 08 04 2022
entrez: 19 5 2022
pubmed: 20 5 2022
medline: 21 5 2022
Statut: epublish

Résumé

In this study, we aimed to determine endothelial dysfunction and ischemia-modified albumin (IMA) levels in patients diagnosed with erectile dysfunction (ED) and to examine the relationship between these and diabetes disease. 86 male patients (46 patients with diabetes, age: 51.5 ± 9.2 and 40 patients with nondiabetes (control group), age: 54.78 ± 12.2) were included in the study. IMA, a new indicator of tissue ischemia and oxidative stress, was checked. Superoxide dismutase (SOD) activity, another oxidative stress indicator, was examined. Endothelin-1 (ET-1), one of the parameters of endothelial dysfunction, was measured. Additionally, endothelial function was evaluated with flow-mediated vasodilatation (FMD). Student's

Identifiants

pubmed: 35585936
doi: 10.1155/2022/3661822
pmc: PMC9110139
doi:

Substances chimiques

Biomarkers 0
Serum Albumin 0
ischemia-modified albumin 0
Superoxide Dismutase EC 1.15.1.1
Serum Albumin, Human ZIF514RVZR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3661822

Informations de copyright

Copyright © 2022 Hasan Anıl Kurt et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

PLoS One. 2017 Feb 28;12(2):e0172751
pubmed: 28245261
Chest. 2005 Jun;127(6):2254-63
pubmed: 15947345
J Sex Med. 2006 May;3(3):382-404; discussion 404-7
pubmed: 16681465
J Clin Invest. 2002 Mar;109(6):817-26
pubmed: 11901190
Vasc Health Risk Manag. 2008;4(5):1061-8
pubmed: 19183753
Vestn Oftalmol. 2013 Jul-Aug;129(4):20-3
pubmed: 24137977
Clin Biochem. 2010 Mar;43(4-5):450-4
pubmed: 19968982
Surgery. 2002 Aug;132(2):173-9
pubmed: 12219008
Am J Cardiol. 2003 Jan 15;91(2):230-1
pubmed: 12521639
Diabetologia. 2009 Aug;52(8):1464-73
pubmed: 19484217
J Am Coll Cardiol. 2006 Dec 19;48(12):2482-4
pubmed: 17174185
Int J Impot Res. 2004 Jun;16 Suppl 1:S15-9
pubmed: 15224130
Rev Med Chir Soc Med Nat Iasi. 2004 Oct-Dec;108(4):777-81
pubmed: 16004216
J Korean Med Sci. 2008 Feb;23(1):77-82
pubmed: 18303203
J Endocrinol Invest. 2014 Sep;37(9):819-27
pubmed: 24957167
Diabetes Metab Res Rev. 2022 Feb;38(2):e3494
pubmed: 34514697
Int J Clin Pract. 2004 Apr;58(4):358-62
pubmed: 15161120
BJU Int. 2005 Jan;95(1):125-30
pubmed: 15638909
Eur J Nutr. 2015 Mar;54(2):301-7
pubmed: 24821271
Invest Urol. 1977 Nov;15(3):194-9
pubmed: 591264
Eur Urol. 2021 Sep;80(3):333-357
pubmed: 34183196
Dis Markers. 2008;24(6):311-7
pubmed: 18688079
J Clin Endocrinol Metab. 2011 May;96(5):1493-9
pubmed: 21346068
J Diabetes Complications. 2012 Mar-Apr;26(2):141-7
pubmed: 22437118
J Urol. 1994 Jan;151(1):54-61
pubmed: 8254833
Adv Cardiol. 2008;45:1-16
pubmed: 18230953
Int J Impot Res. 2004 Aug;16(4):350-3
pubmed: 14985780
Sex Med. 2019 Sep;7(3):292-302
pubmed: 31196744
Diabet Med. 1996 Sep;13(9):800-5
pubmed: 8891455
Diabetes. 1999 Jun;48(6):1331-7
pubmed: 10342824
BJU Int. 2005 Nov;96(7):1079-86
pubmed: 16225532
Eur Urol. 2002 Mar;41(3):298-304
pubmed: 12180232
Vasc Med. 2000;5(1):49-53
pubmed: 10737156
Endocrinol Metab Clin North Am. 2007 Jun;36(2):453-63
pubmed: 17543729
Rev Endocr Metab Disord. 2010 Mar;11(1):61-74
pubmed: 20186491
Clin Chem Lab Med. 2011 Feb;49(2):177-84
pubmed: 21083441
Endocrine. 2009 Dec;36(3):425-32
pubmed: 19784800
Diabetes Care. 1992 Oct;15(10):1396-7
pubmed: 1425108
Am J Physiol. 1991 May;260(5 Pt 2):H1590-5
pubmed: 2035679
Biochem Biophys Res Commun. 2006 Jun 9;344(3):780-5
pubmed: 16631114
J Urol. 2001 May;165(5):1776-82
pubmed: 11342975
J Urol. 1997 Nov;158(5):1966-72
pubmed: 9334651
J Emerg Med. 2000 Nov;19(4):311-5
pubmed: 11074321
Urology. 1997 Jun;49(6):822-30
pubmed: 9187685
Circulation. 2002 Oct 8;106(15):1991-8
pubmed: 12370225
J Urol. 2000 Mar;163(3):788-91
pubmed: 10687978
Vascul Pharmacol. 2005 Jun;43(1):19-29
pubmed: 15955745
J Am Coll Cardiol. 2004 Jan 21;43(2):179-84
pubmed: 14736434

Auteurs

Hasan Anıl Kurt (HA)

Canakkale Onsekiz Mart University, Medical Faculty, Department of Urology, Turkey.

Emrah Demirci (E)

Yozgat City Hospital, Department of Urology, Turkey.

Cabir Alan (C)

Canakkale Onsekiz Mart University, Medical Faculty, Department of Urology, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH